RVP vs. NSPR, SURG, EDAP, HYPR, ICCM, CTCX, MDAI, APT, MLSS, and DXR
Should you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include InspireMD (NSPR), SurgePays (SURG), EDAP TMS (EDAP), Hyperfine (HYPR), IceCure Medical (ICCM), Carmell (CTCX), Spectral AI (MDAI), Alpha Pro Tech (APT), Milestone Scientific (MLSS), and Daxor (DXR). These companies are all part of the "medical equipment" industry.
Retractable Technologies vs. Its Competitors
InspireMD (NYSE:NSPR) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.
44.8% of InspireMD shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 34.1% of InspireMD shares are held by insiders. Comparatively, 57.1% of Retractable Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Retractable Technologies has a net margin of -41.11% compared to InspireMD's net margin of -413.96%. Retractable Technologies' return on equity of -17.15% beat InspireMD's return on equity.
In the previous week, Retractable Technologies had 4 more articles in the media than InspireMD. MarketBeat recorded 4 mentions for Retractable Technologies and 0 mentions for InspireMD. Retractable Technologies' average media sentiment score of 0.50 beat InspireMD's score of 0.00 indicating that Retractable Technologies is being referred to more favorably in the news media.
Retractable Technologies has higher revenue and earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.
InspireMD currently has a consensus price target of $4.50, indicating a potential upside of 99.56%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than Retractable Technologies.
InspireMD has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500.
Summary
Retractable Technologies beats InspireMD on 11 of the 16 factors compared between the two stocks.
Get Retractable Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Retractable Technologies Competitors List
Related Companies and Tools
This page (NYSE:RVP) was last updated on 7/5/2025 by MarketBeat.com Staff
Free RVP Stock Alerts